Evolution of symptoms after ustekinumab induction therapy in patients with Crohn’s disease

By sjmartinez • July 2, 2023

Colombel JF, Sands BE, Gasink C, Yeager B, Adedokun OJ, Izanec J, Ma T, Gao LL, Lee SD, Targan SR, Ghosh S, Hanauer SB, Sandborn WJ. Evolution of symptoms after ustekinumab induction therapy in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2023 Jun 28:S1542-3565(23)00499-8. doi: 10.1016/j.cgh.2023.06.014. Epub ahead of print. PMID: 37391056.

Tags: Cedars Sinai DoM, Crohn’s disease, Digestive Diseases, efficacy dynamics, Publications, remission, response, ustekinumab

Related Posts

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

Bandos H, Kim S, Henry NL, Hays RD, Calsavara VF, Luu M, Gresham G, Lu KY, Irvin WJ, Suga JM, Siddique S, Cecchini RS, Rogatko[...]

Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial

Kar S, Makkar RR, Whisenant BK, Hamid N, Naik H, Tadros P, Price MJ, Singh G, Schwartz JG, Kapadia S, Alli O, Horr S, Seshiah[...]

Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial

Lindman BR, Pibarot P, Schwartz A, Oldemeyer JB, Su YR, Goel K, Cohen DJ, Fearon WF, Babaliaros V, Daniels D, Chhatriwalla A, Suradi HS, Shah[...]